Filing Details
- Accession Number:
- 0000899243-15-004744
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-09-14 16:30:27
- Reporting Period:
- 2015-09-10
- Filing Date:
- 2015-09-14
- Accepted Time:
- 2015-09-14 16:30:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1042418 | Hedgepath Pharmaceuticals Inc. | HPPI | Services-Commercial Physical & Biological Research (8731) | 541641133 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1066040 | Jr E Francis Odonnell | 324 S. Hyde Park Avenue, Suite 350 Tampa FL 33606 | Executive Chairman | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $.0001 Par Value Per Share | Acquisiton | 2015-09-10 | 20,000,000 | $0.00 | 20,000,000 | No | 4 | P | Indirect | By Hopkins Capital Group II, LLC |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By Hopkins Capital Group II, LLC |
Footnotes
- On the September 10, 2015, Hedgepath, LLC transferred 20,000,000 shares of common stock to Hopkins Capital Group II, LLC ("HCGII") in satisfaction of $1,577,797.54 in then outstanding debt.
- The shares are owned by HCGII. The Reporting Person is the co-manager of HCGII. Filing of this statement shall not be deemed an admission by the Reporting Person that he beneficially owns the securities held by HCGII. The Reporting Person disclaims ownership of all securities held by HCGII.
Billionaire Hedge Funds
